Nitric Oxide Interacts with Caveolin-1 to Facilitate Autophagy-Lysosome-Mediated Claudin-5 Degradation in Oxygen-Glucose Deprivation-Treated Endothelial Cells
Overview
Neurology
Affiliations
Using in vitro oxygen-glucose deprivation (OGD) model, we have previously demonstrated that 2-h OGD induces rapid, caveolin-1-mediated dissociation of claudin-5 from the cellular cytoskeletal framework and quick endothelial barrier disruption. In this study, we further investigated the fate of translocated claudin-5 and the mechanisms by which OGD promotes caveolin-1 translocation. Exposure of bEND3 cells to 4-h OGD, but not 2-h OGD plus 2-h reoxygenation, resulted in claudin-5 degradation. Inhibition of autophagy or the fusion of autophagosome with lysosome, but not proteasome, blocked OGD-induced claudin-5 degradation. Moreover, knockdown of caveolin-1 with siRNA blocked OGD-induced claudin-5 degradation. Western blot analysis showed a transient colocalization of caveolin-1, claudin-5, and LC3B in autolysosome or lipid raft fractions at 2-h OGD. Of note, inhibiting autophagosome and lysosome fusion sustained the colocalization of caveolin-1, claudin-5, and LC3B throughout the 4-h OGD exposure. EPR spin trapping showed increased nitric oxide (NO) generation in 2-h OGD-treated cells, and inhibiting NO with its scavenger C-PTIO or inducible nitric oxide synthase (iNOS) inhibitor 1400W prevented OGD-induced caveolin-1 translocation and claudin-5 degradation. Taken together, our data provide a novel mechanism underlying endothelial barrier disruption under prolonged ischemic conditions, in which NO promotes caveolin-1-mediated delivery of claudin-5 to the autophagosome for autophagy-lysosome-dependent degradation.
Li Y, Quan X, Hu J, Han Y, Chen J, Zhou M Int J Biol Sci. 2025; 21(2):842-859.
PMID: 39781452 PMC: 11705626. DOI: 10.7150/ijbs.101937.
Dutta A, Chakraborty A, Ghosh T, Kumar A Sci Rep. 2024; 14(1):23387.
PMID: 39379402 PMC: 11461840. DOI: 10.1038/s41598-024-73143-y.
Dithmer S, Blasig I, Fraser P, Qin Z, Haseloff R Int J Mol Sci. 2024; 25(11).
PMID: 38891789 PMC: 11172262. DOI: 10.3390/ijms25115601.
Alterations in brain fluid physiology during the early stages of development of ischaemic oedema.
Hladky S, Barrand M Fluids Barriers CNS. 2024; 21(1):51.
PMID: 38858667 PMC: 11163777. DOI: 10.1186/s12987-024-00534-8.
Wang Y, Du W, Hu X, Yu X, Guo C, Jin X Acta Pharm Sin B. 2023; 13(12):4667-4687.
PMID: 38045038 PMC: 10692395. DOI: 10.1016/j.apsb.2023.08.009.